CVS Caremark to cover Foundayo, Zepbound obesity drugs
UPI
—
https://cdnph.upi.com/ph/st/th/8181779988280/2026/upi/9fa05160350e1d9e850bf29a0969fd5b/v1.5/CVS-Caremark-to-cover-Foundayo-Zepbound-obesity-drugs.jpg" /> CVS Caremark will start covering Eli Lilly's Foundayo and resume covering its Zepbound obesity drugs in the next several months, the companies said.
- Lillyโs GLP-1 medications will soon be covered by CVS, potentially opening access for millions of Americans MarketWatch —
- Weight-loss drugs like GLP-1s are easy to buy online, raising overdose and safety concerns NBC News —
- Alarming rise in weight loss drug overdoses NBC News —
- Alarming rise in weight loss drug GLP-1 overdoses ๐น NBC News — ยท 3min
- CVS expands access to blockbuster weight-loss drugs in surprise reversal The Independent —